TY - JOUR
T1 - Clinical significance of serum KL-6 in pulmonary sarcoidosis
AU - Kondo, R.
AU - Horiguchi, T.
AU - Teruya, S.
AU - Banno, K.
AU - Ishibashi, A.
AU - Sasaki, Y.
AU - Handa, M.
AU - Tachikawa, S.
PY - 2001/11
Y1 - 2001/11
N2 - We investigated whether the level of serum KL-6 could be an activity marker for pulmonary sarcoidosis. In 33 patients with pulmonary sarcoidosis, the relationships between serum KL-6 levels and diagnostic imaging, serum angiotensin-converting enzyme (ACE) levels, serum lysozyme levels, steroid therapy, and prognosis were evaluated. There were no significant differences in the level of serum KL-6 when the patients were divided on the basis of radiographic findings, but the level of serum KL-6 was markedly elevated in some patients with stage-II pulmonary sarcoidosis. There was a significant correlation between serum KL-6 levels and the following two parameters: serum ACE and lysozyme levels. Among patients with a high initial level of serum KL-6, pulmonary sarcoidosis tended to become exacerbated within one year. Steroid therapy significantly decreased the level of serum KL-6, suggesting that the level of serum KL-6 could be an activity indicator for pulmonary sarcoidosis. Immunohistochemical staining by anti-KL-6 antibody revealed that KL-6 was localized in proliferating type-II alveolar epithelial cells.
AB - We investigated whether the level of serum KL-6 could be an activity marker for pulmonary sarcoidosis. In 33 patients with pulmonary sarcoidosis, the relationships between serum KL-6 levels and diagnostic imaging, serum angiotensin-converting enzyme (ACE) levels, serum lysozyme levels, steroid therapy, and prognosis were evaluated. There were no significant differences in the level of serum KL-6 when the patients were divided on the basis of radiographic findings, but the level of serum KL-6 was markedly elevated in some patients with stage-II pulmonary sarcoidosis. There was a significant correlation between serum KL-6 levels and the following two parameters: serum ACE and lysozyme levels. Among patients with a high initial level of serum KL-6, pulmonary sarcoidosis tended to become exacerbated within one year. Steroid therapy significantly decreased the level of serum KL-6, suggesting that the level of serum KL-6 could be an activity indicator for pulmonary sarcoidosis. Immunohistochemical staining by anti-KL-6 antibody revealed that KL-6 was localized in proliferating type-II alveolar epithelial cells.
UR - http://www.scopus.com/inward/record.url?scp=0035524682&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035524682&partnerID=8YFLogxK
M3 - Article
C2 - 11855079
AN - SCOPUS:0035524682
SN - 1343-3490
VL - 39
SP - 823
EP - 828
JO - Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
JF - Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
IS - 11
ER -